Hofseth BioCare ASA (HOFBF)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.76 Million | -10.87 Million | -7.2 Million | -7.75 Million | -3.85 Million | -28.62 Million |
| Net Income | -106.68 Million | -13.98 Million | -14.32 Million | -11.92 Million | -10.15 Million | -84.52 Million |
| Depreciation & Amortization | 36.41 Million | -3.1 Million | -3.32 Million | -2.78 Million | -2.86 Million | 22.19 Million |
| Deferred income taxes | - | -2.34 Million | -3.09 Million | - | -826.99 Thousand | - |
| Stock-based compensation | - | 2.34 Million | 3.09 Million | - | 827 Thousand | - |
| Change in working capital | 84.48 Million | 407.80 | 4 Million | 1.5 Million | 3.49 Million | 30.34 Million |
| Other non-cash items | 9.49 Million | 6.2 Million | 6.44 Million | 5.44 Million | 5.66 Million | -14.2 Million |
| Investing Cash Flow | -14.99 Million | -1.79 Million | -4.29 Million | -7.01 Million | -3.09 Million | -9.83 Million |
| Investments in PPE | -14.06 Million | -1.79 Million | -4.27 Million | -6.36 Million | -3.27 Million | -9.83 Million |
| Acquisitions | -1.61 Million | - | -188 Thousand | -6.51 Million | - | - |
| Investment purchases | - | - | -21.29 Thousand | -761.15 Thousand | - | - |
| Sales/Maturities of investments | - | - | 1.00 | 918 Thousand | 449 Thousand | - |
| Other Investing Activities | -6.79 Million | -13.75 Million | 187.99 Thousand | 5.7 Million | -262.93 Thousand | -2.3 Million |
| Financing Cash Flow | 3.69 Million | 10.89 Million | -2.42 Million | 23.91 Million | 11.31 Million | 45.03 Million |
| Debt repayment | -27.04 Million | -3.54 Million | -264.34 Thousand | -2.56 Million | -1.11 Million | -30.19 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -21.1 Thousand | 14.44 Million | - | 28.06 Million | 11.95 Million | 72.21 Million |
| Other Financing Activities | -10.47 Million | -102.20 | -2.15 Million | -1.58 Million | 464.98 Thousand | -768 Thousand |
| Accounts receivables | -777 Thousand | -406.06 Thousand | 473.19 Thousand | -1.01 Million | 1.04 Million | 12 Million |
| Accounts payables | 5.24 Million | 2.2 Million | 4.44 Million | 6.45 Million | -273.12 Thousand | - |
| Inventory | 33.98 Million | -2.62 Million | -1.98 Million | -4.59 Million | -521.66 Thousand | -12.54 Million |
| Other working capital | 141.87 Million | 827.63 Thousand | 1.07 Million | 666.2 Thousand | 3.24 Million | 50.69 Million |
| Cash at beginning of period | 32.42 Million | 49.92 Million | 172.83 Million | 94.55 Million | 48.64 Million | 42.06 Million |
| Cash at end of period | 23.89 Million | 32.42 Million | 49.92 Million | 172.83 Million | 94.55 Million | 48.64 Million |
| Capital Expenditure | -14.06 Million | -1.79 Million | -4.27 Million | -6.36 Million | -3.27 Million | -9.83 Million |
| Effect of forex changes on cash | 0.22 | -15.71 Million | -108.99 Million | 69.13 Million | 41.54 Million | - |
| Net cash flow / Change in cash | -8.53 Million | -17.49 Million | -122.91 Million | 78.28 Million | 45.91 Million | 6.57 Million |
| Free Cash Flow | -11.3 Million | -12.67 Million | -11.47 Million | -14.11 Million | -7.13 Million | -38.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.64 Million | -2.68 Million | -106.68 Million | -5.09 Million | -2.12 Million | 536.39 Thousand |
| Depreciation & Amortization | 781.39 Thousand | 807.48 Thousand | 36.41 Million | 931.97 Thousand | 841.34 Thousand | 926.41 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.24 Million | -343.91 Thousand | 84.48 Million | 1.84 Million | 2.11 Million | 776.86 Thousand |
| Other non-cash items | -744.7 Thousand | 2.14 Million | 9.49 Million | -29.94 Thousand | -13.73 Thousand | -2.18 Million |
| Investing Cash Flow | -79.73 Thousand | -152.55 Thousand | -14.99 Million | -818.58 Thousand | -754.36 Thousand | -256.47 Thousand |
| Investments in PPE | -79.73 Thousand | -152.55 Thousand | -14.06 Million | -818.58 Thousand | -754.36 Thousand | -256.56 Thousand |
| Acquisitions | - | - | -1.61 Million | 67.24 Thousand | - | - |
| Investment purchases | - | - | - | -158.55 Thousand | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -852 Thousand | - | -6.79 Million | -1.66 Million | 1000.00 | 93.00 |
| Financing Cash Flow | 647.85 Thousand | 2.09 Million | 3.69 Million | 4.14 Million | -280.91 Thousand | -367.68 Thousand |
| Debt repayment | -647.66 Thousand | -2.12 Million | -27.04 Million | -4.16 Million | -280.82 Thousand | -367.68 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | -26.98 Thousand | -21.1 Thousand | -21.1 Thousand | - | - |
| Other Financing Activities | -1000.00 | -1000.00 | -10.47 Million | 98.00 | -93.00 | -1000.00 |
| Accounts receivables | -336.23 Thousand | -790.66 Thousand | -777 Thousand | 140.88 Thousand | 195.62 Thousand | -233.76 Thousand |
| Accounts payables | 937.57 Thousand | 487.87 Thousand | 5.24 Million | -194.77 Thousand | 1.2 Million | 1.73 Million |
| Inventory | 1.05 Million | -108.29 Thousand | 33.98 Million | 1.86 Million | 800.42 Thousand | -128.51 Thousand |
| Other working capital | -414.84 Thousand | 67.17 Thousand | 141.87 Million | 31.9 Thousand | -89.68 Thousand | -594.09 Thousand |
| Cash at beginning of period | 2.04 Million | 2.34 Million | 32.42 Million | 1.65 Million | 1.55 Million | 2.18 Million |
| Cash at end of period | 2.36 Million | 2.04 Million | 23.89 Million | 2.34 Million | 1.65 Million | 1.55 Million |
| Capital Expenditure | -79.73 Thousand | -152.55 Thousand | -14.06 Million | -818.58 Thousand | -754.36 Thousand | -256.56 Thousand |
| Effect of forex changes on cash | - | - | 0.22 | -0.67 | -0.90 | 0.32 |
| Net cash flow / Change in cash | 320.63 Thousand | -298.27 Thousand | -8.53 Million | 694.76 Thousand | 94.3 Thousand | -624.98 Thousand |
| Free Cash Flow | -353.26 Thousand | -2.25 Million | -11.3 Million | -3.21 Million | 66.51 Thousand | -202.68 Thousand |
ELRXF
ECRFF
MEDHLP
BIOCON
0JSP
NTRBW